Vancouver General Hospital

Vancouver V6Z 1Y6

9 studies enrolling now · 20 studies all time

What they study most

Acute Gastrointestinal Bleeding, Acute Myocardial Infarction, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, Chronic Graft-versus-host-disease, Coronary Artery Disease, Crohn's Disease, Diabetes Mellitus, Type 1, Heart Failure With Left Bundle Branch Block, Idiopathic Pulmonary Fibrosis, Impaired Hypoglycemic Awareness

Studies at this site

• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Recruiting now
• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
• A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes — Recruiting now
• Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding — Recruiting now
• TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease — Running, not enrolling
• Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells — Enrolling by invitation
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation — Completed
• AdaptResponse Clinical Trial — Completed
• New Strategy to Predict Early Sepsis — Status unconfirmed
• Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment — Completed
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension — Completed